SLC1A5 and breast carcinoma: The glutamine metabolism-related proteins, such as GLS-1, glutamate dehydrogenase (GDH), and ASCT2 were found to be highly expressed in HER2-positive breast cancer than other subtypes, which indicated that HER2-positive breast cancer had the highest glutamine metabolism activity (19).